Asthma devices – what pharmacists should know

• In: C4 - Managing patients with asthma: The role of the pharmacist on Thursday, 5 September 2013, 09:00-12:00
• At: Dublin (Ireland) (2013)
• Type: Presentation
• By: LUNDBäCK, Hans (AstraZeneca, Pharmaceutical Development, Mölndal, Sweden)
• Abstract:

  It is obvious from clinical studies reported in the literature that inhaler therapy with respect to asthma control and COPD outcomes is sub-optimal in clinical practice compared to the controlled situation in clinical trials. There are surely numerous of reasons to this discrepancy, but the primary cause is probably poor inhaler device handling

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login